Immunostimulatory effects of the muramyl dipeptide analogue LK415 in chickens immunized with a vaccine strain of infectious bursal disease virus

Acta Veterinaria Hungarica

Volumn 48, Issue 2, 2000, Pages 237-248

  Zorman Rojs, Olga ^a   Černe, Manica ^a   Mrzel, I ^a   Urleb, U ^a   Muraoka, Shizuko ^b  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b Fujimoto Pharmaceutical Corporation   (Japan)

Author keywords

Chickens; Immune response; Infectious bursal disease; Muramyl dipeptide; Vaccination

Indexed keywords

DRUG DERIVATIVE; IMMUNOLOGICAL ADJUVANT; LEVAMISOLE; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINE;

ANIMAL; ANIMAL DISEASE; ANTIBODY PRODUCTION; ARTICLE; CHICKEN; DOSE RESPONSE; IMMUNIZATION; IMMUNOLOGY; INFECTIOUS BURSAL DISEASE VIRUS; VIRUS INFECTION;

ACETYLMURAMYL-ALANYL-ISOGLUTAMINE; ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODY FORMATION; BIRNAVIRIDAE INFECTIONS; CHICKENS; DOSE-RESPONSE RELATIONSHIP, DRUG; IMMUNIZATION; INFECTIOUS BURSAL DISEASE VIRUS; LEVAMISOLE;

EID: 0345807657     PISSN: 02366290     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Chenchev, I., Kostov, G., Cholakova, R. and Bonovska, M. (1981): Trials with levamisole to stimulate immunity against Newcastle disease in poultry. Vet. Med. Nauki 18, 104-108.
2. Da Silva Martins, N. R., Mockett, A. P. A. and Cook, J. K. A. (1992): The immunoglobulin M response in chicken serum to infectious bursal disease virus. Avian Pathol. 21, 517-521.
3. Ellouz, F., Adam, A., Ciobaru, R. and Lederer, E. (1974): Minimal requirements for adjuvant activity of bacterial peptidoglycan derivatives. Biochem. Biophys. Res. Comm. 59, 1317-1325.
4. Furuse, K. and Sakuma, A. (1989): Activation of the cytokine network by muroctasin as a remedy for leukopenia and thrombopenia. Arzneimittelforsch. 39, 915-917.
5. LeClerc, C., Juy, D. Y., Bourgeois, E. and Chedid, L. (1979): In vivo regulation of humoral and cellular immune responses of mice by a synthetic adjuvant, N-acetyl-muramyl-L-alanyl-D-isoglutamine, muramyl dipeptide for MDP. Cell. Immunol. 45, 199-206.
6. Lopez-Bernstein, G. L., Mehta, K., Mehta, R., Juliana, R. L. and Hersh, E. M. (1983): The activation of human monocytes by liposome-encapsulated muramyl dipeptide analogues. J. Immunol. 130, 1500-1502.
7. Lowenthal, J. W., York, J. J., O'Neil, T. E., Steven, R. A., Strom, D. G. and Digby, M. R. (1998): Potential use of cytokine therapy in poultry. Vet. Immunol. Immunopathol. 63, 191-198.
8. Lukert, P. D. and Saif, Y. M. (1997): Infectious bursal disease. In: Calnek, B. W., Barnes, H. J., Beard, C. W., McDougald, L. R. and Saif, Y. M. (eds) Diseases of Poultry. 10th edn, Mosby-Wolfe, London. pp. 648-663.
9. Maheswaran, S. K., Dua, S. K. and Thies, E. S. (1979): Studies on Pasteurella multocida IX. Levamisole-induced augmentation of immune responses to a live fowl cholera vaccine. Avian Dis. 24, 71-81.
10. Neumann, U., Wischner, H. and Siegmann, O. (1982): Lack of immunostimulatory effect of N-acetyl-l-alanyl-D-isoglutamine on selected chicken immune functions. Comp. Imm. Microbiol. Infect. Dis. 5, 413-421.
11. Nunoya, T., Otaki, Y., Tajima, M., Hirage, M. and Saito, T. (1992): Occurrence of acute infectious bursal disease with high mortality in Japan and pathogenicity of field isolates in specific pathogen free chickens. Avian Dis. 36, 597-609.
12. Ochi, C., Norisada, N., Moriguchi, M., Štalc, A., Urleb, U. and Muraoka, S. (1999): Interleukin-10 inducing activity of a phtalimido desmuramyldipeptide compound. Arzneimittelforsch. 49, 72-79.
13. Ozaki, T., Maeda, M. and Hayashi, H. (1989): Role of alveolar macrophages in neutrophil-dependent defense system against Pseudomonas aeruginosa infection in the lower respiratory tract. Amplifying effect of muramyl dipeptide analog. Am. Rev. Respir. Dis. 140, 1595-1601.
14. Payne, L. N. and Howes, K. (1980): Lack of beneficial effect of levamisole on Marek's disease. Avian Pathol. 9, 525-529.
15. Paludan, S. P. (1998): Interleukin-4 and interferon gamma: the quintessence of a mutual antagonistic relationship. Scand. J. Immunol. 48, 459-468.
16. Pečar, S., Sollner, M., Urleb, U., Kiklej, D., Marc, G., Krbavčič, A., Kotnik, V., Wraber, B., Simčič, S., Klampfer, L., Povšič, L., Kopitar, Z. and Štalc, A. (1996): N-acyldipeptides, processes for the preparation thereof and pharmaceutical compositions containing the same. US Pat. 5, 514, 654.
17. Rodenberg, J. J., Sharma, J. M., Belzer, S. W., Nordgren, R. M. and Nagi, S. (1994): Flow cytometric analysis of B cell and T cell subpopulations in specific pathogen free chickens infected with infectious bursal disease virus. Avian Dis. 38, 16-21.
18. Schijns, V. E. C. J., Wierda, C. M. H., Vahlenkamp, T. W., Horzinek, M. C. and DeGroot, R. J. (1995): Molecular cloning and expression of cat interferon-gamma. Immunogenetics 42, 440-441.
19. Singh, K. C. P. and Dhawedkar, R. G. (1993): Immunomodulating effects of levamisole in chicks immunocompromised by infectious bursal disease virus. Trop. Anim. Health Prod. 25, 11-14.
20. Skeeles, J. K., Lukert, P. D., De Buysscher, E. V., Fletcher, O. J. and Brown, J. (1979): Infectious bursal disease virus infections. II. The relationship of age, complement levels, virus-neutralizing antibody, clotting and lesions. Avian Dis. 23, 95-106.
21. Sollner, M., Kotnik, V., Pečar, S., Štalc, A., Simčič, S., Povšič, L., Herzog Wraber, B., Klampfer, L., Ihan, L. and Grosman, P. (1993): Apyrogenic synthetic desmuramyldipeptide, LK 409, with immunomodulatory properties. Agents Actions 38, 273-280.
22. Sollner, M., Pečar, S., Povšič, L. and Štalc, A. (1995): Chemical synthesis and immunological characteristics of new acyclic MDP-derivative, LK 404. Pharm. Pharmacol. Lett. 1, 38-40.
23. Sollner, M., Pečar, S., Povšič, L. and Štalc, A. (1996): Immunological characteristics of the new acyldipeptides from the LK 409 series. In: Schneider, C. H. (ed.) Peptides in Immunology. John Wiley and Sons Ltd., New York. pp. 285-289.
24. Tamura, M., Yoo, Y. C., Yoshimatsu, K., Yoshida, R., Oka, T., Ohkuma, K., Arikawa, J. and Azuma, I. (1995): Effect of muramyl dipeptide derivatives as adjuvants on the induction of antibody response to recombinant hepatitis B surface antigen. Vaccine 13, 77-82.
25. Yoo, Y. C., Saiki, I., Sato, K. and Azuma, I. (1992): B30-MDP, a synthetic muramyl dipeptide derivate for tumor vaccination to enhance antitumor immunity and antimetastatic effect in mice. Vaccine 10, 792-797.
26. Yoo, C. Y., Yoshimatsu, K., Koike, Y., Hatsise, R., Yamanishi, K., Tanishita, O., Arikawa, J. and Azuma, I. (1998): Adjuvant activity of muramyl dipeptide derivatives to enhance immunogenicity of a hantavirus-inactivated vaccine. Vaccine 16, 216-224.